1. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008; 118:1479–1490.
2. Macleod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchison GR, et al. Androgen action in the masculinization programming window and development of male reproductive organs. Int J Androl. 2010; 33:279–287.
3. van den Driesche S, Scott HM, MacLeod DJ, Fisken M, Walker M, Sharpe RM. Relative importance of prenatal and postnatal androgen action in determining growth of the penis and anogenital distance in the rat before, during and after puberty. Int J Androl. 2011; 34(6 Pt 2):e578–e586.
4. Drake AJ, van den Driesche S, Scott HM, Hutchison GR, Seckl JR, Sharpe RM. Glucocorticoids amplify dibutyl phthalate-induced disruption of testosterone production and male reproductive development. Endocrinology. 2009; 150:5055–5064.
5. Kim KS, Liu W, Cunha GR, Russell DW, Huang H, Shapiro E, et al. Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra. Cell Tissue Res. 2002; 307:145–153.
6. Eisenberg ML, Jensen TK, Walters RC, Skakkebaek NE, Lipshultz LI. The relationship between anogenital distance and reproductive hormone levels in adult men. J Urol. 2012; 187:594–598.
7. Buck JJ, Williams RM, Hughes IA, Acerini CL. In-utero androgen exposure and 2nd to 4th digit length ratio-comparisons between healthy controls and females with classical congenital adrenal hyperplasia. Hum Reprod. 2003; 18:976–979.
8. Chung KH, Choi H, Kim SW. Penile and testicular sizes of Korean children. Korean J Urol. 1987; 28:255–258.
9. Wiygul J, Palmer LS. Micropenis. ScientificWorldJournal. 2011; 11:1462–1469.
10. Tsang S. When size matters: a clinical review of pathological micropenis. J Pediatr Health Care. 2010; 24:231–240.
11. Lee JH, Ji YH, Lee SK, Hwang HH, Ryu DS, Kim KS, et al. Change in penile length in children: preliminary study. Korean J Urol. 2012; 53:870–874.
12. Kim TH, Lee HH. Anogenital distance in newborns. Reprod Biomed Online. 2014; 29:771.
13. Dean A, Sharpe RM. Clinical review: anogenital distance or digit length ratio as measures of fetal androgen exposure: relationship to male reproductive development and its disorders. J Clin Endocrinol Metab. 2013; 98:2230–2238.
14. Matsuo N, Ishii T, Takayama JI, Miwa M, Hasegawa T. Reference standard of penile size and prevalence of buried penis in Japanese newborn male infants. Endocr J. 2014; 61:849–853.
15. Thankamony A, Ong KK, Dunger DB, Acerini CL, Hughes IA. Anogenital distance from birth to 2 years: a population study. Environ Health Perspect. 2009; 117:1786–1790.
16. Manning JT. Digit ratio (2D:4D), sex differences, allometry, and finger length of 12-30-year olds: evidence from the British Broadcasting Corporation (BBC) Internet study. Am J Hum Biol. 2010; 22:604–608.
17. Salazar-Martinez E, Romano-Riquer P, Yanez-Marquez E, Longnecker MP, Hernandez-Avila M. Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ Health. 2004; 3:8.
18. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005; 113:1056–1061.
19. Ventura T, Gomes MC, Pita A, Neto MT, Taylor A. Digit ratio (2D:4D) in newborns: influences of prenatal testosterone and maternal environment. Early Hum Dev. 2013; 89:107–112.
20. Lu H, Huo ZH, Liu YJ, Shi ZY, Zhao JL. Correlations between digit ratio and infertility in Chinese men. Early Hum Dev. 2012; 88:865–869.
21. Manning JT, Barley L, Walton J, Lewis-Jones DI, Trivers RL, Singh D, et al. The 2nd:4th digit ratio, sexual dimorphism, population differences, and reproductive success. evidence for sexually antagonistic genes. Evol Hum Behav. 2000; 21:163–183.
22. Auger J, Eustache F. Second to fourth digit ratios, male genital development and reproductive health: a clinical study among fertile men and testis cancer patients. Int J Androl. 2011; 34(4 Pt 2):e49–e58.